Effects of opioid rotation in chronic pain patients

Clinical Drug Investigation

Volumn 30, Issue SUPPL. 2, 2010, Pages 39-47

  Gatti, Antonio ^a   Reale, Carlo ^b   Luzi, Marta ^b   Canneti, Alessandra ^b   Mediati, Rocco Domenico ^c   Vellucci, Renato ^c   Mammucari, Massimo ^a   Sabato, Alessandro Fabrizio ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CYCLOOXYGENASE 2 INHIBITOR; FENTANYL; HYDROMORPHONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; DELAYED RELEASE FORMULATION; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CANCER PAIN; CHRONIC PAIN; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLOW RELEASE FORMULATION; AGED; CHRONIC DISEASE; DELAYED RELEASE FORMULATION; DRUG ADMINISTRATION; DRUG COMBINATION; ITALY; MIDDLE AGED; PAIN; PAIN MEASUREMENT; TIME; TREATMENT OUTCOME;

AGED; ANALGESICS, OPIOID; CHRONIC DISEASE; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MORPHINE; PAIN; PAIN MEASUREMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955102400     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/1158413-S0-000000000-00000     Document Type: Article

References (17)

1. Hanks GW, Conno F, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001 Mar 2; 84 (5): 587-593
2. Ripamonti CI, Campa T, Fagnoni E, et al. Normal-release oral morphine starting dose in cancer patients with pain. Clin J Pain 2009 Jun; 25 (5): 386-390
3. Gatti A, Reale C, Occhioni R, et al. Standard therapy with opioids in chronic pain management: ORTIBER study. Clin Drug Investig 2009; 29 Suppl. 1: 17-23
4. Geppetti P, Benemei S. Pain treatment with opioids: achieving the minimal effective and the minimal interacting dose. Clin Drug Investig 2009; 29 Suppl. 1: 3-16
5. Mercadante S, Porzio G, Ferrera P, et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain 2008 Nov; 12 (8): 1040-1046
6. Klepstad P, Kaasa S, Jystad A, et al. Immediate- or sustainedrelease morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial. Pain 2003 Jan; 101 (1-2): 193-198
7. Fine PG, Portenoy RK. Establishing "best practices" for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage 2009 Sep; 38 (3): 418-425
8. Knotkova H, Fine PG, Portenoy RK. Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manage 2009 Sep; 38 (3): 426-439
9. Shaheen PE,WalshD, Lasheen W, et al. Opioid equianalgesic tables: are they all equally dangerous? J Pain Symptom Manage 2009 Sep; 38 (3): 409-417
10. De Conno F, Ripamonti C, Fagnoni E, et al. The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during ?titration phase? in patients with cancer pain. Palliat Med 2008 Apr; 22 (3): 214-221
11. Gordon DB, Dahl JL, Miaskowski C, et al. American pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force. Arch Intern Med 2005 Jul 25; 165 (14): 1574-1580
12. Ambrosio F, Finco G, Mattia C, et al. SIAARTI recommendations for chronic noncancer pain. Minerva Anestesiol 2006 Nov; 72 (11): 859-880
13. Mercadante S. Opioid rotation for cancer pain: rationale and clinical aspects. Cancer 1999 Nov 1; 86 (9): 1856-1866
14. Duttaroy A, Yoburn BC. The effect of intrinsic efficacy on opioid tolerance. Anesthesiology 1995May; 82 (5): 1226-1236
15. Adams JU, Paronis CA, Holtzman SG. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine. J Pharmacol Exp Ther 1990 Dec; 255 (3): 1027-1032
16. Nickerson M. Receptor occupancy and tissue response. Nature 1956 Sep 29; 178 (4535): 697-698
17. Stephenson RP. A modification of receptor theory. Br J Pharmacol Chemother 1956 Dec; 11 (4): 379-393